Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Definitive Healthcare (DH) Other Non Operating Income (2020 - 2025)

Definitive Healthcare's Other Non Operating Income history spans 6 years, with the latest figure at $16.6 million for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 124.35% year-over-year to $16.6 million; the TTM value through Dec 2025 reached $16.5 million, up 137.12%, while the annual FY2025 figure was $15.0 million, N/A changed from the prior year.
  • Other Non Operating Income reached $16.6 million in Q4 2025 per DH's latest filing, up from -$109000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $23.8 million in Q3 2024 to a low of -$68.1 million in Q4 2024.
  • Average Other Non Operating Income over 5 years is -$427684.2, with a median of $119000.0 recorded in 2021.
  • Peak YoY movement for Other Non Operating Income: tumbled 426.67% in 2023, then skyrocketed 27796.51% in 2024.
  • A 5-year view of Other Non Operating Income shows it stood at -$1.8 million in 2021, then surged by 148.92% to $863000.0 in 2022, then surged by 2383.89% to $21.4 million in 2023, then tumbled by 417.8% to -$68.1 million in 2024, then skyrocketed by 124.35% to $16.6 million in 2025.
  • Per Business Quant, the three most recent readings for DH's Other Non Operating Income are $16.6 million (Q4 2025), -$109000.0 (Q3 2025), and -$497000.0 (Q2 2025).